Ocular hypotensive effect of tafluprost in latanoprost low-responder cynomolgus monkeys

Kurashima H., Asai Y., Aihara M., Ishida N., Nakamura M., Araie M.

2012
Journal of Glaucoma

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Research and Development Center, Santen Pharmaceutical Co., Ltd, Nara, Japan; Graduate School of Biological Sciences, Nara Institute of Science and Technology, Nara, Japan; Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan

Related Publications

Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study

Hanyuda A.; Raita Y.; Ninomiya T.; Hashimoto K.; Takada N.; Sato K.; Inoue J.; Koshiba S.; Tamiya G.; Narita A.; Akiyama M.; Omodaka K.; Tsuda S.; Yokoyama Y.; Himori N.; Yamamoto Y.; Taniguchi T.; Negishi K.; Nakazawa T.

Ocular Tissue Distribution of Omidenepag Isopropyl in Rabbits and Cynomolgus Monkeys

Yamamura K.; Mano H.; Fuwa M.; Ryoiwamura; Odani-Kawabata N.

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

View all Glaucoma publications